{"transactions":[{"id":932091,"issuer":{"id":3496,"kind":"organization","name":"GLOBUS MEDICAL INC","symbol":"GMED"},"owners":[{"id":68880,"kind":"person","name":"Paul David C","position":1,"cik":"0001555391","reported_name":"Paul David C","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Executive Chairman"}}],"security":"Stock Option (Right to Buy Class A Common Stock)","published_at":"2026-01-23T22:03:28.000Z","date":"2026-01-21","kind":"grant","planned":false,"acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"These options were granted on January 21, 2026, and vest over a four-year period with 1/4 of the options vesting on January 1, 2027, then 1/48 of the options vesting each month thereafter."}],"balance_after":100000,"derivative":{"exercise_price":94.15,"expiration_date":"2036-01-21","underlying":"Class A Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001193125-26-021239","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1237831/000119312526021239/ownership.xml","form_type":"4"}},{"id":974274,"issuer":{"id":3496,"kind":"organization","name":"GLOBUS MEDICAL INC","symbol":"GMED"},"owners":[{"id":68880,"kind":"person","name":"Paul David C","position":1,"cik":"0001555391","reported_name":"Paul David C","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Executive Chairman"}}],"security":"Stock Option (Right to Buy Class A Common Stock)","published_at":"2025-12-10T21:37:18.000Z","date":"2025-12-08","kind":"exercise","planned":false,"acquired":false,"shares":34375,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"These options were granted on January 25, 2016 and are fully vested."}],"balance_after":0,"derivative":{"exercise_price":25.52,"expiration_date":"2026-01-25","underlying":"Class A Common Stock","underlying_shares":34375},"source":{"system":"sec-edgar","filing":"0001193125-25-314329","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1237831/000119312525314329/ownership.xml","form_type":"4"}},{"id":974273,"issuer":{"id":3496,"kind":"organization","name":"GLOBUS MEDICAL INC","symbol":"GMED"},"owners":[{"id":68880,"kind":"person","name":"Paul David C","position":1,"cik":"0001555391","reported_name":"Paul David C","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Executive Chairman"}}],"security":"Class A Common Stock","published_at":"2025-12-10T21:37:18.000Z","date":"2025-12-08","kind":"exercise","planned":false,"acquired":true,"shares":34375,"price":25.52,"value":877250.0,"ownership":{"direct":true},"balance_after":60417,"source":{"system":"sec-edgar","filing":"0001193125-25-314329","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1237831/000119312525314329/ownership.xml","form_type":"4"}},{"id":1188733,"issuer":{"id":3496,"kind":"organization","name":"GLOBUS MEDICAL INC","symbol":"GMED"},"owners":[{"id":68880,"kind":"person","name":"Paul David C","position":1,"cik":"0001555391","reported_name":"Paul David C","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Executive Chairman"}}],"security":"Stock Option (Right to Buy Class A Common Stock)","published_at":"2025-03-28T23:04:31.000Z","date":"2025-01-23","kind":"grant","planned":false,"acquired":true,"shares":75000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"These options were granted on January 23, 2025, and vest over a four-year period with one-fourth (1/4) of the options granted vesting on January 1, 2026, the first anniversary of the vesting commencement date, and the balance of the options granted vesting ratably on a monthly basis over the following 36 months."}],"balance_after":75000,"derivative":{"exercise_price":92.42,"expiration_date":"2035-01-23","underlying":"Class A Common Stock","underlying_shares":75000},"source":{"system":"sec-edgar","filing":"0000950170-25-047036","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1237831/000095017025047036/ownership.xml","form_type":"4"}},{"id":1357044,"issuer":{"id":3496,"kind":"organization","name":"GLOBUS MEDICAL INC","symbol":"GMED"},"owners":[{"id":68880,"kind":"person","name":"Paul David C","position":1,"cik":"0001555391","reported_name":"Paul David C","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Executive Chairman"}}],"security":"Stock Option (Right to Buy Class A Common Stock)","published_at":"2024-11-20T21:15:44.000Z","date":"2024-11-15","kind":"exercise","planned":false,"acquired":false,"shares":26042,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"These options were granted on January 20, 2015 and are fully vested."}],"balance_after":0,"derivative":{"exercise_price":24.1,"expiration_date":"2025-01-20","underlying":"Class A Common Stock","underlying_shares":26042},"source":{"system":"sec-edgar","filing":"0000950170-24-129270","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1237831/000095017024129270/ownership.xml","form_type":"4"}},{"id":1357043,"issuer":{"id":3496,"kind":"organization","name":"GLOBUS MEDICAL INC","symbol":"GMED"},"owners":[{"id":68880,"kind":"person","name":"Paul David C","position":1,"cik":"0001555391","reported_name":"Paul David C","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Executive Chairman"}}],"security":"Class A Common Stock","published_at":"2024-11-20T21:15:44.000Z","date":"2024-11-15","kind":"exercise","planned":false,"acquired":true,"shares":26042,"price":24.1,"value":627612.2,"ownership":{"direct":true},"balance_after":26042,"source":{"system":"sec-edgar","filing":"0000950170-24-129270","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1237831/000095017024129270/ownership.xml","form_type":"4"}},{"id":1666385,"issuer":{"id":3496,"kind":"organization","name":"GLOBUS MEDICAL INC","symbol":"GMED"},"owners":[{"id":68880,"kind":"person","name":"Paul David C","position":1,"cik":"0001555391","reported_name":"Paul David C","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Executive Chairman"}}],"security":"Stock Option (Right to Buy Class A Common Stock)","published_at":"2024-01-30T21:33:47.000Z","date":"2024-01-26","kind":"grant","planned":false,"acquired":true,"shares":75000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"These options were granted on January 26, 2024, and vest over a four-year period with one-fourth (1/4) of the options granted vesting on January 1, 2025, the first anniversary of the vesting commencement date, and the balance of the options granted vesting ratably on a monthly basis over the following 36 months."}],"balance_after":75000,"derivative":{"exercise_price":53.75,"expiration_date":"2034-01-26","underlying":"Class A Common Stock","underlying_shares":75000},"source":{"system":"sec-edgar","filing":"0000950170-24-008878","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1237831/000095017024008878/ownership.xml","form_type":"4"}},{"id":1718960,"issuer":{"id":3496,"kind":"organization","name":"GLOBUS MEDICAL INC","symbol":"GMED"},"owners":[{"id":68880,"kind":"person","name":"Paul David C","position":1,"cik":"0001555391","reported_name":"Paul David C","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Executive Chairman"}}],"security":"Class B Common Stock","published_at":"2023-12-07T22:06:51.000Z","date":"2023-12-05","kind":"gift","planned":false,"acquired":true,"shares":171100,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By The Sonali Paul Children's Irrevocable Trust"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"From the date of acquisition, the Company's Class B Common Stock converts into the Company's Class A Common Stock on a one-for-one basis (i) at the option of the holder, (ii) upon certain transfers, (iii) upon the closing of the Company's initial public offering if at that time the Company's Class B Common Stock that the holder beneficially owns is less than 10% of the aggregate number of all outstanding shares of the Company's common stock, and (iv) immediately if, at any time following the initial public offering of the Company's common stock, the Company's Class B Common Stock that the holder beneficially owns represents less than 5% of all outstanding shares of the Company's common stock."},{"field":"kind","element":"transactionCoding","label":"F2","text":"This transaction involved a gift by the reporting person and his spouse of a total of 342,200 shares of Class B Common Stock to trusts for the benefit of their children."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"From the date of acquisition, the Company's Class B Common Stock converts into the Company's Class A Common Stock on a one-for-one basis (i) at the option of the holder, (ii) upon certain transfers, (iii) upon the closing of the Company's initial public offering if at that time the Company's Class B Common Stock that the holder beneficially owns is less than 10% of the aggregate number of all outstanding shares of the Company's common stock, and (iv) immediately if, at any time following the initial public offering of the Company's common stock, the Company's Class B Common Stock that the holder beneficially owns represents less than 5% of all outstanding shares of the Company's common stock."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"From the date of acquisition, the Company's Class B Common Stock converts into the Company's Class A Common Stock on a one-for-one basis (i) at the option of the holder, (ii) upon certain transfers, (iii) upon the closing of the Company's initial public offering if at that time the Company's Class B Common Stock that the holder beneficially owns is less than 10% of the aggregate number of all outstanding shares of the Company's common stock, and (iv) immediately if, at any time following the initial public offering of the Company's common stock, the Company's Class B Common Stock that the holder beneficially owns represents less than 5% of all outstanding shares of the Company's common stock."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"These shares are held in a trust for the benefit of a child of the reporting person. The reporting person is trustee of the trust."}],"balance_after":171100,"derivative":{"underlying":"Class A Common Stock","underlying_shares":171100},"source":{"system":"sec-edgar","filing":"0000950170-23-068856","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1237831/000095017023068856/ownership.xml","form_type":"4"}},{"id":1718959,"issuer":{"id":3496,"kind":"organization","name":"GLOBUS MEDICAL INC","symbol":"GMED"},"owners":[{"id":68880,"kind":"person","name":"Paul David C","position":1,"cik":"0001555391","reported_name":"Paul David C","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Executive Chairman"}}],"security":"Class B Common Stock","published_at":"2023-12-07T22:06:51.000Z","date":"2023-12-05","kind":"gift","planned":false,"acquired":true,"shares":171100,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By The David C. Paul Children's Trust"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"From the date of acquisition, the Company's Class B Common Stock converts into the Company's Class A Common Stock on a one-for-one basis (i) at the option of the holder, (ii) upon certain transfers, (iii) upon the closing of the Company's initial public offering if at that time the Company's Class B Common Stock that the holder beneficially owns is less than 10% of the aggregate number of all outstanding shares of the Company's common stock, and (iv) immediately if, at any time following the initial public offering of the Company's common stock, the Company's Class B Common Stock that the holder beneficially owns represents less than 5% of all outstanding shares of the Company's common stock."},{"field":"kind","element":"transactionCoding","label":"F2","text":"This transaction involved a gift by the reporting person and his spouse of a total of 342,200 shares of Class B Common Stock to trusts for the benefit of their children."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"From the date of acquisition, the Company's Class B Common Stock converts into the Company's Class A Common Stock on a one-for-one basis (i) at the option of the holder, (ii) upon certain transfers, (iii) upon the closing of the Company's initial public offering if at that time the Company's Class B Common Stock that the holder beneficially owns is less than 10% of the aggregate number of all outstanding shares of the Company's common stock, and (iv) immediately if, at any time following the initial public offering of the Company's common stock, the Company's Class B Common Stock that the holder beneficially owns represents less than 5% of all outstanding shares of the Company's common stock."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"From the date of acquisition, the Company's Class B Common Stock converts into the Company's Class A Common Stock on a one-for-one basis (i) at the option of the holder, (ii) upon certain transfers, (iii) upon the closing of the Company's initial public offering if at that time the Company's Class B Common Stock that the holder beneficially owns is less than 10% of the aggregate number of all outstanding shares of the Company's common stock, and (iv) immediately if, at any time following the initial public offering of the Company's common stock, the Company's Class B Common Stock that the holder beneficially owns represents less than 5% of all outstanding shares of the Company's common stock."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"These shares are held in a trust for the benefit of a child of the reporting person. The reporting person disclaims beneficial ownership of these securities, and the filing of this report is not an admission that the reporting person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose."}],"balance_after":171100,"derivative":{"underlying":"Class A Common Stock","underlying_shares":171100},"source":{"system":"sec-edgar","filing":"0000950170-23-068856","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1237831/000095017023068856/ownership.xml","form_type":"4"}},{"id":1718958,"issuer":{"id":3496,"kind":"organization","name":"GLOBUS MEDICAL INC","symbol":"GMED"},"owners":[{"id":68880,"kind":"person","name":"Paul David C","position":1,"cik":"0001555391","reported_name":"Paul David C","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Executive Chairman"}}],"security":"Class B Common Stock","published_at":"2023-12-07T22:06:51.000Z","date":"2023-12-05","kind":"gift","planned":false,"acquired":false,"shares":342200,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"From the date of acquisition, the Company's Class B Common Stock converts into the Company's Class A Common Stock on a one-for-one basis (i) at the option of the holder, (ii) upon certain transfers, (iii) upon the closing of the Company's initial public offering if at that time the Company's Class B Common Stock that the holder beneficially owns is less than 10% of the aggregate number of all outstanding shares of the Company's common stock, and (iv) immediately if, at any time following the initial public offering of the Company's common stock, the Company's Class B Common Stock that the holder beneficially owns represents less than 5% of all outstanding shares of the Company's common stock."},{"field":"kind","element":"transactionCoding","label":"F2","text":"This transaction involved a gift by the reporting person and his spouse of a total of 342,200 shares of Class B Common Stock to trusts for the benefit of their children."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"From the date of acquisition, the Company's Class B Common Stock converts into the Company's Class A Common Stock on a one-for-one basis (i) at the option of the holder, (ii) upon certain transfers, (iii) upon the closing of the Company's initial public offering if at that time the Company's Class B Common Stock that the holder beneficially owns is less than 10% of the aggregate number of all outstanding shares of the Company's common stock, and (iv) immediately if, at any time following the initial public offering of the Company's common stock, the Company's Class B Common Stock that the holder beneficially owns represents less than 5% of all outstanding shares of the Company's common stock."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"From the date of acquisition, the Company's Class B Common Stock converts into the Company's Class A Common Stock on a one-for-one basis (i) at the option of the holder, (ii) upon certain transfers, (iii) upon the closing of the Company's initial public offering if at that time the Company's Class B Common Stock that the holder beneficially owns is less than 10% of the aggregate number of all outstanding shares of the Company's common stock, and (iv) immediately if, at any time following the initial public offering of the Company's common stock, the Company's Class B Common Stock that the holder beneficially owns represents less than 5% of all outstanding shares of the Company's common stock."}],"balance_after":20525324,"derivative":{"underlying":"Class A Common Stock","underlying_shares":342200},"source":{"system":"sec-edgar","filing":"0000950170-23-068856","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1237831/000095017023068856/ownership.xml","form_type":"4"}},{"id":1989951,"issuer":{"id":3496,"kind":"organization","name":"GLOBUS MEDICAL INC","symbol":"GMED"},"owners":[{"id":68880,"kind":"person","name":"Paul David C","position":1,"cik":"0001555391","reported_name":"Paul David C","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Executive Chairman"}}],"security":"Stock Option (Right to Buy Class A Common Stock)","published_at":"2023-02-27T21:50:44.000Z","date":"2023-01-26","kind":"grant","acquired":true,"shares":75000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"These options were granted on January 26, 2023, and vest over a four-year period with one-fourth (1/4) of the options granted vesting on January 1, 2024, the first anniversary of the vesting commencement date, and the balance of the options granted vesting ratably on a monthly basis over the following 36 months."}],"balance_after":75000,"derivative":{"exercise_price":75.18,"expiration_date":"2033-01-26","underlying":"Class A Common Stock","underlying_shares":75000},"source":{"system":"sec-edgar","filing":"0001209191-23-013213","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1237831/000120919123013213/doc4.xml","form_type":"4"}},{"id":2420962,"issuer":{"id":3496,"kind":"organization","name":"GLOBUS MEDICAL INC","symbol":"GMED"},"owners":[{"id":68880,"kind":"person","name":"Paul David C","position":1,"cik":"0001555391","reported_name":"Paul David C","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Executive Chairman"}}],"security":"Stock Option (Right to Buy Class A Common Stock)","published_at":"2022-01-31T21:37:54.000Z","date":"2022-01-27","kind":"grant","acquired":true,"shares":75000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"These options were granted on January 27, 2022, and vest over a four-year period with one-fourth (1/4) of the options granted vesting on January 1, 2023, the first anniversary of the vesting commencement date, and the balance of the options granted vesting ratably on a monthly basis over the following 36 months."}],"balance_after":75000,"derivative":{"exercise_price":63.68,"expiration_date":"2032-01-27","underlying":"Class A Common Stock","underlying_shares":75000},"source":{"system":"sec-edgar","filing":"0001209191-22-005571","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1237831/000120919122005571/doc4.xml","form_type":"4"}},{"id":2904085,"issuer":{"id":3496,"kind":"organization","name":"GLOBUS MEDICAL INC","symbol":"GMED"},"owners":[{"id":68880,"kind":"person","name":"Paul David C","position":1,"cik":"0001555391","reported_name":"Paul David C","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Executive Chairman"}}],"security":"Stock Option (Right to Buy Class A Common Stock)","published_at":"2021-01-19T21:39:17.000Z","date":"2021-01-14","kind":"grant","acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"These options were granted on January 14, 2021, and vest over a four-year period with one-fourth (1/4) of the options granted vesting on January 1, 2022, the first anniversary of the vesting commencement date, and the balance of the options granted vesting ratably on a monthly basis over the following 36 months."}],"balance_after":100000,"derivative":{"exercise_price":65.05,"expiration_date":"2031-01-14","underlying":"Class A Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001209191-21-004030","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1237831/000120919121004030/doc4.xml","form_type":"4"}},{"id":3302737,"issuer":{"id":3496,"kind":"organization","name":"GLOBUS MEDICAL INC","symbol":"GMED"},"owners":[{"id":68880,"kind":"person","name":"Paul David C","position":1,"cik":"0001555391","reported_name":"Paul David C","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Executive Chairman"}}],"security":"Stock Option (Right to Buy Class A Common Stock)","published_at":"2020-01-24T21:37:34.000Z","date":"2020-01-22","kind":"grant","acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"These options were granted on January 22, 2020, and vest over a four-year period with one-fourth (1/4) of the options granted vesting on January 1, 2021, the first anniversary of the vesting commencement date, and the balance of the options granted vesting ratably on a monthly basis over the following 36 months."}],"balance_after":100000,"derivative":{"exercise_price":53.27,"expiration_date":"2030-01-22","underlying":"Class A Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001209191-20-004841","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1237831/000120919120004841/doc4.xml","form_type":"4"}},{"id":3665648,"issuer":{"id":3496,"kind":"organization","name":"GLOBUS MEDICAL INC","symbol":"GMED"},"owners":[{"id":68880,"kind":"person","name":"Paul David C","position":1,"cik":"0001555391","reported_name":"Paul David C","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Executive Chairman"}}],"security":"Stock Option (Right to Buy Class A Common Stock)","published_at":"2019-02-11T21:44:44.000Z","date":"2019-01-22","kind":"grant","acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"These options were granted on January 22, 2019, and vest over a four-year period with one-fourth (1/4) of the options granted vesting on January 1, 2020, the first anniversary of the vesting commencement date, and the balance of the options granted vesting ratably on a monthly basis over the following 36 months."}],"balance_after":100000,"derivative":{"exercise_price":43.58,"expiration_date":"2029-01-22","underlying":"Class A Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001209191-19-008984","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1237831/000120919119008984/doc4.xml","form_type":"4"}},{"id":3807136,"issuer":{"id":3496,"kind":"organization","name":"GLOBUS MEDICAL INC","symbol":"GMED"},"owners":[{"id":68880,"kind":"person","name":"Paul David C","position":1,"cik":"0001555391","reported_name":"Paul David C","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Executive Chairman"}}],"security":"Class B Common Stock","published_at":"2018-09-27T00:15:43.000Z","date":"2018-09-25","kind":"exercise","acquired":false,"shares":748845,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F7","text":"From the date of acquisition, the Company's Class B Common Stock converts into the Company's Class A Common Stock on a one-for-one basis (i) at the option of the holder, (ii) upon certain transfers, (iii) upon the closing of the Company's initial public offering if at that time the Company's Class B Common Stock that the holder beneficially owns is less than 10% of the aggregate number of all outstanding shares of the Company's common stock, and (iv) immediately if, at any time following the initial public offering of the Company's common stock, the Company's Class B Common Stock that the holder beneficially owns represents less than 5% of all outstanding shares of the Company's common stock."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"The Company's Class B Common Stock converted into the Company's Class A Common Stock on a one-for-one basis at the election of the reporting person and has no expiration date."},{"field":"shares","element":"transactionShares","label":"F3","text":"The Company's Class B Common Stock converted into the Company's Class A Common Stock on a one-for-one basis at the election of the reporting person and has no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The Company's Class B Common Stock converted into the Company's Class A Common Stock on a one-for-one basis at the election of the reporting person and has no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The Company's Class B Common Stock converted into the Company's Class A Common Stock on a one-for-one basis at the election of the reporting person and has no expiration date."}],"balance_after":20867524,"derivative":{"underlying":"Class A Common Stock","underlying_shares":748845},"source":{"system":"sec-edgar","filing":"0001209191-18-052374","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/1237831/000120919118052374/doc4.xml","form_type":"4"}},{"id":3807135,"issuer":{"id":3496,"kind":"organization","name":"GLOBUS MEDICAL INC","symbol":"GMED"},"owners":[{"id":68880,"kind":"person","name":"Paul David C","position":1,"cik":"0001555391","reported_name":"Paul David C","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Executive Chairman"}}],"security":"Class B Common Stock","published_at":"2018-09-27T00:15:43.000Z","date":"2018-09-24","kind":"exercise","acquired":false,"shares":101320,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F7","text":"From the date of acquisition, the Company's Class B Common Stock converts into the Company's Class A Common Stock on a one-for-one basis (i) at the option of the holder, (ii) upon certain transfers, (iii) upon the closing of the Company's initial public offering if at that time the Company's Class B Common Stock that the holder beneficially owns is less than 10% of the aggregate number of all outstanding shares of the Company's common stock, and (iv) immediately if, at any time following the initial public offering of the Company's common stock, the Company's Class B Common Stock that the holder beneficially owns represents less than 5% of all outstanding shares of the Company's common stock."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"The Company's Class B Common Stock converted into the Company's Class A Common Stock on a one-for-one basis at the election of the reporting person and has no expiration date."},{"field":"shares","element":"transactionShares","label":"F3","text":"The Company's Class B Common Stock converted into the Company's Class A Common Stock on a one-for-one basis at the election of the reporting person and has no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The Company's Class B Common Stock converted into the Company's Class A Common Stock on a one-for-one basis at the election of the reporting person and has no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The Company's Class B Common Stock converted into the Company's Class A Common Stock on a one-for-one basis at the election of the reporting person and has no expiration date."}],"balance_after":21616369,"derivative":{"underlying":"Class A Common Stock","underlying_shares":101320},"source":{"system":"sec-edgar","filing":"0001209191-18-052374","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1237831/000120919118052374/doc4.xml","form_type":"4"}},{"id":3807134,"issuer":{"id":3496,"kind":"organization","name":"GLOBUS MEDICAL INC","symbol":"GMED"},"owners":[{"id":68880,"kind":"person","name":"Paul David C","position":1,"cik":"0001555391","reported_name":"Paul David C","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Executive Chairman"}}],"security":"Class B Common Stock","published_at":"2018-09-27T00:15:43.000Z","date":"2018-09-24","kind":"exercise","acquired":false,"shares":298647,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Sonali Paul Children's Trust"},"footnotes":[{"field":"security","element":"securityTitle","label":"F7","text":"From the date of acquisition, the Company's Class B Common Stock converts into the Company's Class A Common Stock on a one-for-one basis (i) at the option of the holder, (ii) upon certain transfers, (iii) upon the closing of the Company's initial public offering if at that time the Company's Class B Common Stock that the holder beneficially owns is less than 10% of the aggregate number of all outstanding shares of the Company's common stock, and (iv) immediately if, at any time following the initial public offering of the Company's common stock, the Company's Class B Common Stock that the holder beneficially owns represents less than 5% of all outstanding shares of the Company's common stock."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"The Company's Class B Common Stock converted into the Company's Class A Common Stock on a one-for-one basis at the election of the reporting person and has no expiration date."},{"field":"shares","element":"transactionShares","label":"F3","text":"The Company's Class B Common Stock converted into the Company's Class A Common Stock on a one-for-one basis at the election of the reporting person and has no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The Company's Class B Common Stock converted into the Company's Class A Common Stock on a one-for-one basis at the election of the reporting person and has no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The Company's Class B Common Stock converted into the Company's Class A Common Stock on a one-for-one basis at the election of the reporting person and has no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"These shares are held in a trust for the benefit of a child of the reporting person. The reporting person is trustee of the trust."}],"balance_after":0,"derivative":{"underlying":"Class A Common Stock","underlying_shares":298647},"source":{"system":"sec-edgar","filing":"0001209191-18-052374","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1237831/000120919118052374/doc4.xml","form_type":"4"}},{"id":3807133,"issuer":{"id":3496,"kind":"organization","name":"GLOBUS MEDICAL INC","symbol":"GMED"},"owners":[{"id":68880,"kind":"person","name":"Paul David C","position":1,"cik":"0001555391","reported_name":"Paul David C","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Executive Chairman"}}],"security":"Class B Common Stock","published_at":"2018-09-27T00:15:43.000Z","date":"2018-09-24","kind":"exercise","acquired":false,"shares":298647,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By David C. Paul Children's Trust"},"footnotes":[{"field":"security","element":"securityTitle","label":"F7","text":"From the date of acquisition, the Company's Class B Common Stock converts into the Company's Class A Common Stock on a one-for-one basis (i) at the option of the holder, (ii) upon certain transfers, (iii) upon the closing of the Company's initial public offering if at that time the Company's Class B Common Stock that the holder beneficially owns is less than 10% of the aggregate number of all outstanding shares of the Company's common stock, and (iv) immediately if, at any time following the initial public offering of the Company's common stock, the Company's Class B Common Stock that the holder beneficially owns represents less than 5% of all outstanding shares of the Company's common stock."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"The Company's Class B Common Stock converted into the Company's Class A Common Stock on a one-for-one basis at the election of the reporting person and has no expiration date."},{"field":"shares","element":"transactionShares","label":"F3","text":"The Company's Class B Common Stock converted into the Company's Class A Common Stock on a one-for-one basis at the election of the reporting person and has no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The Company's Class B Common Stock converted into the Company's Class A Common Stock on a one-for-one basis at the election of the reporting person and has no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The Company's Class B Common Stock converted into the Company's Class A Common Stock on a one-for-one basis at the election of the reporting person and has no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"These shares are held in a trust for the benefit of a child of the reporting person. The reporting person disclaims beneficial ownership of these securities, and the filing of this report is not an admission that the reporting person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose."}],"balance_after":0,"derivative":{"underlying":"Class A Common Stock","underlying_shares":298647},"source":{"system":"sec-edgar","filing":"0001209191-18-052374","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1237831/000120919118052374/doc4.xml","form_type":"4"}},{"id":3807132,"issuer":{"id":3496,"kind":"organization","name":"GLOBUS MEDICAL INC","symbol":"GMED"},"owners":[{"id":68880,"kind":"person","name":"Paul David C","position":1,"cik":"0001555391","reported_name":"Paul David C","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Executive Chairman"}}],"security":"Class A Common Stock","published_at":"2018-09-27T00:15:43.000Z","date":"2018-09-25","kind":"sale","acquired":false,"shares":748845,"price":54.6964,"value":40959125.658,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This sale was effected pursuant to a Rule 10b5-1 trading plan executed by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $54.00 to $55.00, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (6) to this Form 4."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001209191-18-052374","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1237831/000120919118052374/doc4.xml","form_type":"4"}},{"id":3807131,"issuer":{"id":3496,"kind":"organization","name":"GLOBUS MEDICAL INC","symbol":"GMED"},"owners":[{"id":68880,"kind":"person","name":"Paul David C","position":1,"cik":"0001555391","reported_name":"Paul David C","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Executive Chairman"}}],"security":"Class A Common Stock","published_at":"2018-09-27T00:15:43.000Z","date":"2018-09-25","kind":"exercise","acquired":true,"shares":748845,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The Company's Class B Common Stock converted into the Company's Class A Common Stock on a one-for-one basis at the election of the reporting person and has no expiration date."}],"balance_after":748845,"source":{"system":"sec-edgar","filing":"0001209191-18-052374","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1237831/000120919118052374/doc4.xml","form_type":"4"}},{"id":3807130,"issuer":{"id":3496,"kind":"organization","name":"GLOBUS MEDICAL INC","symbol":"GMED"},"owners":[{"id":68880,"kind":"person","name":"Paul David C","position":1,"cik":"0001555391","reported_name":"Paul David C","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Executive Chairman"}}],"security":"Class A Common Stock","published_at":"2018-09-27T00:15:43.000Z","date":"2018-09-24","kind":"sale","acquired":false,"shares":101320,"price":54.0126,"value":5472556.632,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This sale was effected pursuant to a Rule 10b5-1 trading plan executed by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $54.00 to $54.26, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001209191-18-052374","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1237831/000120919118052374/doc4.xml","form_type":"4"}},{"id":3807129,"issuer":{"id":3496,"kind":"organization","name":"GLOBUS MEDICAL INC","symbol":"GMED"},"owners":[{"id":68880,"kind":"person","name":"Paul David C","position":1,"cik":"0001555391","reported_name":"Paul David C","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Executive Chairman"}}],"security":"Class A Common Stock","published_at":"2018-09-27T00:15:43.000Z","date":"2018-09-24","kind":"exercise","acquired":true,"shares":101320,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The Company's Class B Common Stock converted into the Company's Class A Common Stock on a one-for-one basis at the election of the reporting person and has no expiration date."}],"balance_after":101320,"source":{"system":"sec-edgar","filing":"0001209191-18-052374","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1237831/000120919118052374/doc4.xml","form_type":"4"}},{"id":3807128,"issuer":{"id":3496,"kind":"organization","name":"GLOBUS MEDICAL INC","symbol":"GMED"},"owners":[{"id":68880,"kind":"person","name":"Paul David C","position":1,"cik":"0001555391","reported_name":"Paul David C","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Executive Chairman"}}],"security":"Class A Common Stock","published_at":"2018-09-27T00:15:43.000Z","date":"2018-09-24","kind":"sale","acquired":false,"shares":298647,"price":54.0126,"value":16130700.9522,"ownership":{"direct":false,"nature":"By Sonali Paul Children's Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This sale was effected pursuant to a Rule 10b5-1 trading plan executed by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $54.00 to $54.26, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"These shares are held in a trust for the benefit of a child of the reporting person. The reporting person is trustee of the trust."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001209191-18-052374","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1237831/000120919118052374/doc4.xml","form_type":"4"}},{"id":3807127,"issuer":{"id":3496,"kind":"organization","name":"GLOBUS MEDICAL INC","symbol":"GMED"},"owners":[{"id":68880,"kind":"person","name":"Paul David C","position":1,"cik":"0001555391","reported_name":"Paul David C","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Executive Chairman"}}],"security":"Class A Common Stock","published_at":"2018-09-27T00:15:43.000Z","date":"2018-09-24","kind":"exercise","acquired":true,"shares":298647,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Sonali Paul Children's Trust"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The Company's Class B Common Stock converted into the Company's Class A Common Stock on a one-for-one basis at the election of the reporting person and has no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"These shares are held in a trust for the benefit of a child of the reporting person. The reporting person is trustee of the trust."}],"balance_after":298647,"source":{"system":"sec-edgar","filing":"0001209191-18-052374","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1237831/000120919118052374/doc4.xml","form_type":"4"}},{"id":3807126,"issuer":{"id":3496,"kind":"organization","name":"GLOBUS MEDICAL INC","symbol":"GMED"},"owners":[{"id":68880,"kind":"person","name":"Paul David C","position":1,"cik":"0001555391","reported_name":"Paul David C","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Executive Chairman"}}],"security":"Class A Common Stock","published_at":"2018-09-27T00:15:43.000Z","date":"2018-09-24","kind":"sale","acquired":false,"shares":298647,"price":54.0126,"value":16130700.9522,"ownership":{"direct":false,"nature":"By David C. Paul Children's Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This sale was effected pursuant to a Rule 10b5-1 trading plan executed by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $54.00 to $54.26, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"These shares are held in a trust for the benefit of a child of the reporting person. The reporting person disclaims beneficial ownership of these securities, and the filing of this report is not an admission that the reporting person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001209191-18-052374","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1237831/000120919118052374/doc4.xml","form_type":"4"}},{"id":3807125,"issuer":{"id":3496,"kind":"organization","name":"GLOBUS MEDICAL INC","symbol":"GMED"},"owners":[{"id":68880,"kind":"person","name":"Paul David C","position":1,"cik":"0001555391","reported_name":"Paul David C","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Executive Chairman"}}],"security":"Class A Common Stock","published_at":"2018-09-27T00:15:43.000Z","date":"2018-09-24","kind":"exercise","acquired":true,"shares":298647,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By David C. Paul Children's Trust"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The Company's Class B Common Stock converted into the Company's Class A Common Stock on a one-for-one basis at the election of the reporting person and has no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"These shares are held in a trust for the benefit of a child of the reporting person. The reporting person disclaims beneficial ownership of these securities, and the filing of this report is not an admission that the reporting person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose."}],"balance_after":298647,"source":{"system":"sec-edgar","filing":"0001209191-18-052374","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1237831/000120919118052374/doc4.xml","form_type":"4"}},{"id":3807124,"issuer":{"id":3496,"kind":"organization","name":"GLOBUS MEDICAL INC","symbol":"GMED"},"owners":[{"id":68880,"kind":"person","name":"Paul David C","position":1,"cik":"0001555391","reported_name":"Paul David C","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Executive Chairman"}}],"security":"Class A Common Stock","published_at":"2018-09-27T00:15:43.000Z","date":"2018-09-24","kind":"sale","acquired":false,"shares":605871,"price":54.0126,"value":32724667.9746,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This sale was effected pursuant to a Rule 10b5-1 trading plan executed by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $54.00 to $54.26, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001209191-18-052374","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1237831/000120919118052374/doc4.xml","form_type":"4"}},{"id":3864379,"issuer":{"id":3496,"kind":"organization","name":"GLOBUS MEDICAL INC","symbol":"GMED"},"owners":[{"id":68880,"kind":"person","name":"Paul David C","position":1,"cik":"0001555391","reported_name":"Paul David C","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Executive Chairman"}}],"security":"Class A Common Stock","published_at":"2018-07-20T00:16:02.000Z","date":"2018-07-17","kind":"sale","acquired":false,"shares":6841,"price":52.95,"value":362230.95,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This sale was effected pursuant to a Rule 10b5-1 trading plan executed by the reporting person."}],"balance_after":605871,"source":{"system":"sec-edgar","filing":"0001209191-18-043403","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1237831/000120919118043403/doc4.xml","form_type":"4"}},{"id":3953537,"issuer":{"id":3496,"kind":"organization","name":"GLOBUS MEDICAL INC","symbol":"GMED"},"owners":[{"id":68880,"kind":"person","name":"Paul David C","position":1,"cik":"0001555391","reported_name":"Paul David C","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Executive Chairman"}}],"security":"Stock Option (Right to Buy Class A Common Stock)","published_at":"2018-05-01T00:59:27.000Z","date":"2018-04-26","kind":"exercise","acquired":false,"shares":43750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F13","text":"These options were granted on January 30, 2017, and vest over a four-year period with one-fourth (1/4) of the options granted vesting on January 1, 2018, the first anniversary of the vesting commencement date, and the balance of the options granted vesting ratably on a monthly basis over the following 36 months"}],"balance_after":106250,"derivative":{"exercise_price":26.27,"expiration_date":"2027-01-30","underlying":"Class A Common Stock","underlying_shares":43750},"source":{"system":"sec-edgar","filing":"0001209191-18-026950","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":30,"url":"https://www.sec.gov/Archives/edgar/data/1237831/000120919118026950/doc4.xml","form_type":"4"}},{"id":3953536,"issuer":{"id":3496,"kind":"organization","name":"GLOBUS MEDICAL INC","symbol":"GMED"},"owners":[{"id":68880,"kind":"person","name":"Paul David C","position":1,"cik":"0001555391","reported_name":"Paul David C","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Executive Chairman"}}],"security":"Stock Option (Right to Buy Class A Common Stock)","published_at":"2018-05-01T00:59:27.000Z","date":"2018-04-26","kind":"exercise","acquired":false,"shares":40625,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F12","text":"These options were granted on January 25, 2016, and vest over a four-year period with one-fourth (1/4) of the options granted vesting on January 1, 2017, the first anniversary of the vesting commencement date, and the balance of the options granted vesting ratably on a monthly basis over the following 36 months."}],"balance_after":34375,"derivative":{"exercise_price":25.52,"expiration_date":"2026-01-25","underlying":"Class A Common Stock","underlying_shares":40625},"source":{"system":"sec-edgar","filing":"0001209191-18-026950","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":29,"url":"https://www.sec.gov/Archives/edgar/data/1237831/000120919118026950/doc4.xml","form_type":"4"}},{"id":3953535,"issuer":{"id":3496,"kind":"organization","name":"GLOBUS MEDICAL INC","symbol":"GMED"},"owners":[{"id":68880,"kind":"person","name":"Paul David C","position":1,"cik":"0001555391","reported_name":"Paul David C","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Executive Chairman"}}],"security":"Stock Option (Right to Buy Class A Common Stock)","published_at":"2018-05-01T00:59:27.000Z","date":"2018-04-26","kind":"exercise","acquired":false,"shares":98958,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F11","text":"These options were granted on January 20, 2015, and vest over a four-year period with one-fourth (1/4) of the options granted vesting on January 1, 2016, the first anniversary of the vesting commencement date, and the balance of the options granted vesting ratably on a monthly basis over the following 36 months."}],"balance_after":26042,"derivative":{"exercise_price":24.1,"expiration_date":"2025-01-20","underlying":"Class A Common Stock","underlying_shares":98958},"source":{"system":"sec-edgar","filing":"0001209191-18-026950","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":28,"url":"https://www.sec.gov/Archives/edgar/data/1237831/000120919118026950/doc4.xml","form_type":"4"}},{"id":3953534,"issuer":{"id":3496,"kind":"organization","name":"GLOBUS MEDICAL INC","symbol":"GMED"},"owners":[{"id":68880,"kind":"person","name":"Paul David C","position":1,"cik":"0001555391","reported_name":"Paul David C","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Executive Chairman"}}],"security":"Stock Option (Right to Buy Class A Common Stock)","published_at":"2018-05-01T00:59:27.000Z","date":"2018-04-26","kind":"exercise","acquired":false,"shares":60000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F10","text":"These options were granted on January 23, 2014, and vested over a four-year period with one-fourth (1/4) of the options granted vesting on January 1, 2015, the first anniversary of the vesting commencement date, and the balance of the options granted vesting ratably on a monthly basis over the following 36 months."}],"balance_after":0,"derivative":{"exercise_price":23.95,"expiration_date":"2024-01-23","underlying":"Class A Common Stock","underlying_shares":60000},"source":{"system":"sec-edgar","filing":"0001209191-18-026950","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":27,"url":"https://www.sec.gov/Archives/edgar/data/1237831/000120919118026950/doc4.xml","form_type":"4"}},{"id":3953533,"issuer":{"id":3496,"kind":"organization","name":"GLOBUS MEDICAL INC","symbol":"GMED"},"owners":[{"id":68880,"kind":"person","name":"Paul David C","position":1,"cik":"0001555391","reported_name":"Paul David C","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Executive Chairman"}}],"security":"Stock Option (Right to Buy Class A Common Stock)","published_at":"2018-05-01T00:59:27.000Z","date":"2018-04-26","kind":"exercise","acquired":false,"shares":48000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F9","text":"These options were granted on January 24, 2013, and vested over a four-year period with one-fourth (1/4) of the options granted vesting on January 1, 2014, the first anniversary of the vesting commencement date, and the balance of the options granted vesting ratably on a monthly basis over the following 36 months."}],"balance_after":0,"derivative":{"exercise_price":13.04,"expiration_date":"2023-01-24","underlying":"Class A Common Stock","underlying_shares":48000},"source":{"system":"sec-edgar","filing":"0001209191-18-026950","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":26,"url":"https://www.sec.gov/Archives/edgar/data/1237831/000120919118026950/doc4.xml","form_type":"4"}},{"id":3953532,"issuer":{"id":3496,"kind":"organization","name":"GLOBUS MEDICAL INC","symbol":"GMED"},"owners":[{"id":68880,"kind":"person","name":"Paul David C","position":1,"cik":"0001555391","reported_name":"Paul David C","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Executive Chairman"}}],"security":"Stock Option (Right to Buy Class A Common Stock)","published_at":"2018-05-01T00:59:27.000Z","date":"2018-04-26","kind":"exercise","acquired":false,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"These options were granted on August 29, 2012, and vested over a four-year period with one-fourth (1/4) of the options granted vesting on January 1, 2013, the first anniversary of the vesting commencement date, and the balance of the options granted vesting ratably on a monthly basis over the following 36 months."}],"balance_after":0,"derivative":{"exercise_price":15.34,"expiration_date":"2022-08-29","underlying":"Class A Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001209191-18-026950","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":25,"url":"https://www.sec.gov/Archives/edgar/data/1237831/000120919118026950/doc4.xml","form_type":"4"}},{"id":3953531,"issuer":{"id":3496,"kind":"organization","name":"GLOBUS MEDICAL INC","symbol":"GMED"},"owners":[{"id":68880,"kind":"person","name":"Paul David C","position":1,"cik":"0001555391","reported_name":"Paul David C","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Executive Chairman"}}],"security":"Stock Option (Right to Buy Class A Common Stock)","published_at":"2018-05-01T00:59:27.000Z","date":"2018-04-26","kind":"exercise","acquired":false,"shares":18461,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"These options were granted on October 27, 2011, and vested over a four-year period with one-fourth (1/4) of the options granted vesting on January 1, 2012, the first anniversary of the vesting commencement date, and the balance of the options granted vesting ratably on a monthly basis over the following 36 months."}],"balance_after":0,"derivative":{"exercise_price":10.66,"expiration_date":"2021-10-27","underlying":"Class A Common Stock","underlying_shares":18461},"source":{"system":"sec-edgar","filing":"0001209191-18-026950","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":24,"url":"https://www.sec.gov/Archives/edgar/data/1237831/000120919118026950/doc4.xml","form_type":"4"}},{"id":3953530,"issuer":{"id":3496,"kind":"organization","name":"GLOBUS MEDICAL INC","symbol":"GMED"},"owners":[{"id":68880,"kind":"person","name":"Paul David C","position":1,"cik":"0001555391","reported_name":"Paul David C","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Executive Chairman"}}],"security":"Stock Option (Right to Buy Class A Common Stock)","published_at":"2018-05-01T00:59:27.000Z","date":"2018-04-26","kind":"exercise","acquired":false,"shares":18461,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"These options were granted on June 16, 2010, and vested over a four-year period with one-fourth (1/4) of the options granted vesting on January 1, 2011, the first anniversary of the vesting commencement date, and the balance of the options granted vesting ratably on a monthly basis over the following 36 months."}],"balance_after":0,"derivative":{"exercise_price":11.8625,"expiration_date":"2020-06-16","underlying":"Class A Common Stock","underlying_shares":18461},"source":{"system":"sec-edgar","filing":"0001209191-18-026950","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":23,"url":"https://www.sec.gov/Archives/edgar/data/1237831/000120919118026950/doc4.xml","form_type":"4"}},{"id":3953529,"issuer":{"id":3496,"kind":"organization","name":"GLOBUS MEDICAL INC","symbol":"GMED"},"owners":[{"id":68880,"kind":"person","name":"Paul David C","position":1,"cik":"0001555391","reported_name":"Paul David C","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Executive Chairman"}}],"security":"Stock Option (Right to Buy Class A Common Stock)","published_at":"2018-05-01T00:59:27.000Z","date":"2018-04-26","kind":"exercise","acquired":false,"shares":18461,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"These options were granted on August 6, 2009, and vested over a four-year period with one-fourth (1/4) of the options granted vesting on January 1, 2010, the first anniversary of the vesting commencement date, and the balance of the options granted vesting ratably on a monthly basis over the following 36 months."}],"balance_after":0,"derivative":{"exercise_price":4.88,"expiration_date":"2019-08-06","underlying":"Class A Common Stock","underlying_shares":18461},"source":{"system":"sec-edgar","filing":"0001209191-18-026950","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":22,"url":"https://www.sec.gov/Archives/edgar/data/1237831/000120919118026950/doc4.xml","form_type":"4"}},{"id":3953528,"issuer":{"id":3496,"kind":"organization","name":"GLOBUS MEDICAL INC","symbol":"GMED"},"owners":[{"id":68880,"kind":"person","name":"Paul David C","position":1,"cik":"0001555391","reported_name":"Paul David C","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Executive Chairman"}}],"security":"Class A Common Stock","published_at":"2018-05-01T00:59:27.000Z","date":"2018-04-30","kind":"sale","acquired":false,"shares":72938,"price":51.8053,"value":3778574.9714,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This sale was effected pursuant to a Rule 10b5-1 trading plan executed by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $51.75 to $51.935, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (4) to this Form 4."}],"balance_after":612712,"source":{"system":"sec-edgar","filing":"0001209191-18-026950","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":21,"url":"https://www.sec.gov/Archives/edgar/data/1237831/000120919118026950/doc4.xml","form_type":"4"}},{"id":3953527,"issuer":{"id":3496,"kind":"organization","name":"GLOBUS MEDICAL INC","symbol":"GMED"},"owners":[{"id":68880,"kind":"person","name":"Paul David C","position":1,"cik":"0001555391","reported_name":"Paul David C","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Executive Chairman"}}],"security":"Class A Common Stock","published_at":"2018-05-01T00:59:27.000Z","date":"2018-04-27","kind":"sale","acquired":false,"shares":29066,"price":51.7831,"value":1505127.5846,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This sale was effected pursuant to a Rule 10b5-1 trading plan executed by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $51.75 to $51.8558, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (3) to this Form 4."}],"balance_after":685650,"source":{"system":"sec-edgar","filing":"0001209191-18-026950","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":20,"url":"https://www.sec.gov/Archives/edgar/data/1237831/000120919118026950/doc4.xml","form_type":"4"}},{"id":3953526,"issuer":{"id":3496,"kind":"organization","name":"GLOBUS MEDICAL INC","symbol":"GMED"},"owners":[{"id":68880,"kind":"person","name":"Paul David C","position":1,"cik":"0001555391","reported_name":"Paul David C","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Executive Chairman"}}],"security":"Class A Common Stock","published_at":"2018-05-01T00:59:27.000Z","date":"2018-04-26","kind":"sale","acquired":false,"shares":363284,"price":51.8068,"value":18820581.5312,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This sale was effected pursuant to a Rule 10b5-1 trading plan executed by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $51.80 to $52.155, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4."}],"balance_after":714716,"source":{"system":"sec-edgar","filing":"0001209191-18-026950","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":19,"url":"https://www.sec.gov/Archives/edgar/data/1237831/000120919118026950/doc4.xml","form_type":"4"}},{"id":3953525,"issuer":{"id":3496,"kind":"organization","name":"GLOBUS MEDICAL INC","symbol":"GMED"},"owners":[{"id":68880,"kind":"person","name":"Paul David C","position":1,"cik":"0001555391","reported_name":"Paul David C","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Executive Chairman"}}],"security":"Class A Common Stock","published_at":"2018-05-01T00:59:27.000Z","date":"2018-04-26","kind":"sale","acquired":false,"shares":43750,"price":51.8068,"value":2266547.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This sale was effected pursuant to a Rule 10b5-1 trading plan executed by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $51.80 to $52.155, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4."}],"balance_after":1078000,"source":{"system":"sec-edgar","filing":"0001209191-18-026950","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":18,"url":"https://www.sec.gov/Archives/edgar/data/1237831/000120919118026950/doc4.xml","form_type":"4"}},{"id":3953524,"issuer":{"id":3496,"kind":"organization","name":"GLOBUS MEDICAL INC","symbol":"GMED"},"owners":[{"id":68880,"kind":"person","name":"Paul David C","position":1,"cik":"0001555391","reported_name":"Paul David C","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Executive Chairman"}}],"security":"Class A Common Stock","published_at":"2018-05-01T00:59:27.000Z","date":"2018-04-26","kind":"exercise","acquired":true,"shares":43750,"price":26.27,"value":1149312.5,"ownership":{"direct":true},"balance_after":1121750,"source":{"system":"sec-edgar","filing":"0001209191-18-026950","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":17,"url":"https://www.sec.gov/Archives/edgar/data/1237831/000120919118026950/doc4.xml","form_type":"4"}},{"id":3953523,"issuer":{"id":3496,"kind":"organization","name":"GLOBUS MEDICAL INC","symbol":"GMED"},"owners":[{"id":68880,"kind":"person","name":"Paul David C","position":1,"cik":"0001555391","reported_name":"Paul David C","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Executive Chairman"}}],"security":"Class A Common Stock","published_at":"2018-05-01T00:59:27.000Z","date":"2018-04-26","kind":"sale","acquired":false,"shares":40625,"price":51.8068,"value":2104651.25,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This sale was effected pursuant to a Rule 10b5-1 trading plan executed by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $51.80 to $52.155, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4."}],"balance_after":1078000,"source":{"system":"sec-edgar","filing":"0001209191-18-026950","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":16,"url":"https://www.sec.gov/Archives/edgar/data/1237831/000120919118026950/doc4.xml","form_type":"4"}},{"id":3953522,"issuer":{"id":3496,"kind":"organization","name":"GLOBUS MEDICAL INC","symbol":"GMED"},"owners":[{"id":68880,"kind":"person","name":"Paul David C","position":1,"cik":"0001555391","reported_name":"Paul David C","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Executive Chairman"}}],"security":"Class A Common Stock","published_at":"2018-05-01T00:59:27.000Z","date":"2018-04-26","kind":"exercise","acquired":true,"shares":40625,"price":25.52,"value":1036750.0,"ownership":{"direct":true},"balance_after":1118625,"source":{"system":"sec-edgar","filing":"0001209191-18-026950","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":15,"url":"https://www.sec.gov/Archives/edgar/data/1237831/000120919118026950/doc4.xml","form_type":"4"}},{"id":3953521,"issuer":{"id":3496,"kind":"organization","name":"GLOBUS MEDICAL INC","symbol":"GMED"},"owners":[{"id":68880,"kind":"person","name":"Paul David C","position":1,"cik":"0001555391","reported_name":"Paul David C","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Executive Chairman"}}],"security":"Class A Common Stock","published_at":"2018-05-01T00:59:27.000Z","date":"2018-04-26","kind":"sale","acquired":false,"shares":98958,"price":51.8068,"value":5126697.3144,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This sale was effected pursuant to a Rule 10b5-1 trading plan executed by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $51.80 to $52.155, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4."}],"balance_after":1078000,"source":{"system":"sec-edgar","filing":"0001209191-18-026950","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":14,"url":"https://www.sec.gov/Archives/edgar/data/1237831/000120919118026950/doc4.xml","form_type":"4"}},{"id":3953520,"issuer":{"id":3496,"kind":"organization","name":"GLOBUS MEDICAL INC","symbol":"GMED"},"owners":[{"id":68880,"kind":"person","name":"Paul David C","position":1,"cik":"0001555391","reported_name":"Paul David C","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Executive Chairman"}}],"security":"Class A Common Stock","published_at":"2018-05-01T00:59:27.000Z","date":"2018-04-26","kind":"exercise","acquired":true,"shares":98958,"price":24.1,"value":2384887.8,"ownership":{"direct":true},"balance_after":1176958,"source":{"system":"sec-edgar","filing":"0001209191-18-026950","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/1237831/000120919118026950/doc4.xml","form_type":"4"}},{"id":3953519,"issuer":{"id":3496,"kind":"organization","name":"GLOBUS MEDICAL INC","symbol":"GMED"},"owners":[{"id":68880,"kind":"person","name":"Paul David C","position":1,"cik":"0001555391","reported_name":"Paul David C","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Executive Chairman"}}],"security":"Class A Common Stock","published_at":"2018-05-01T00:59:27.000Z","date":"2018-04-26","kind":"sale","acquired":false,"shares":60000,"price":51.8068,"value":3108408.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This sale was effected pursuant to a Rule 10b5-1 trading plan executed by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $51.80 to $52.155, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4."}],"balance_after":1078000,"source":{"system":"sec-edgar","filing":"0001209191-18-026950","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1237831/000120919118026950/doc4.xml","form_type":"4"}},{"id":3953518,"issuer":{"id":3496,"kind":"organization","name":"GLOBUS MEDICAL INC","symbol":"GMED"},"owners":[{"id":68880,"kind":"person","name":"Paul David C","position":1,"cik":"0001555391","reported_name":"Paul David C","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Executive Chairman"}}],"security":"Class A Common Stock","published_at":"2018-05-01T00:59:27.000Z","date":"2018-04-26","kind":"exercise","acquired":true,"shares":60000,"price":23.95,"value":1437000.0,"ownership":{"direct":true},"balance_after":1138000,"source":{"system":"sec-edgar","filing":"0001209191-18-026950","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1237831/000120919118026950/doc4.xml","form_type":"4"}},{"id":3953517,"issuer":{"id":3496,"kind":"organization","name":"GLOBUS MEDICAL INC","symbol":"GMED"},"owners":[{"id":68880,"kind":"person","name":"Paul David C","position":1,"cik":"0001555391","reported_name":"Paul David C","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Executive Chairman"}}],"security":"Class A Common Stock","published_at":"2018-05-01T00:59:27.000Z","date":"2018-04-26","kind":"sale","acquired":false,"shares":48000,"price":51.8068,"value":2486726.4,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This sale was effected pursuant to a Rule 10b5-1 trading plan executed by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $51.80 to $52.155, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4."}],"balance_after":1078000,"source":{"system":"sec-edgar","filing":"0001209191-18-026950","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1237831/000120919118026950/doc4.xml","form_type":"4"}},{"id":3953516,"issuer":{"id":3496,"kind":"organization","name":"GLOBUS MEDICAL INC","symbol":"GMED"},"owners":[{"id":68880,"kind":"person","name":"Paul David C","position":1,"cik":"0001555391","reported_name":"Paul David C","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Executive Chairman"}}],"security":"Class A Common Stock","published_at":"2018-05-01T00:59:27.000Z","date":"2018-04-26","kind":"exercise","acquired":true,"shares":48000,"price":13.04,"value":625920.0,"ownership":{"direct":true},"balance_after":1126000,"source":{"system":"sec-edgar","filing":"0001209191-18-026950","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1237831/000120919118026950/doc4.xml","form_type":"4"}},{"id":3953515,"issuer":{"id":3496,"kind":"organization","name":"GLOBUS MEDICAL INC","symbol":"GMED"},"owners":[{"id":68880,"kind":"person","name":"Paul David C","position":1,"cik":"0001555391","reported_name":"Paul David C","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Executive Chairman"}}],"security":"Class A Common Stock","published_at":"2018-05-01T00:59:27.000Z","date":"2018-04-26","kind":"sale","acquired":false,"shares":15000,"price":51.8068,"value":777102.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This sale was effected pursuant to a Rule 10b5-1 trading plan executed by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $51.80 to $52.155, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4."}],"balance_after":1078000,"source":{"system":"sec-edgar","filing":"0001209191-18-026950","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1237831/000120919118026950/doc4.xml","form_type":"4"}},{"id":3953514,"issuer":{"id":3496,"kind":"organization","name":"GLOBUS MEDICAL INC","symbol":"GMED"},"owners":[{"id":68880,"kind":"person","name":"Paul David C","position":1,"cik":"0001555391","reported_name":"Paul David C","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Executive Chairman"}}],"security":"Class A Common Stock","published_at":"2018-05-01T00:59:27.000Z","date":"2018-04-26","kind":"exercise","acquired":true,"shares":15000,"price":15.34,"value":230100.0,"ownership":{"direct":true},"balance_after":1093000,"source":{"system":"sec-edgar","filing":"0001209191-18-026950","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1237831/000120919118026950/doc4.xml","form_type":"4"}},{"id":3953513,"issuer":{"id":3496,"kind":"organization","name":"GLOBUS MEDICAL INC","symbol":"GMED"},"owners":[{"id":68880,"kind":"person","name":"Paul David C","position":1,"cik":"0001555391","reported_name":"Paul David C","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Executive Chairman"}}],"security":"Class A Common Stock","published_at":"2018-05-01T00:59:27.000Z","date":"2018-04-26","kind":"sale","acquired":false,"shares":18461,"price":51.8068,"value":956405.3348,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This sale was effected pursuant to a Rule 10b5-1 trading plan executed by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $51.80 to $52.155, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4."}],"balance_after":1078000,"source":{"system":"sec-edgar","filing":"0001209191-18-026950","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1237831/000120919118026950/doc4.xml","form_type":"4"}},{"id":3953512,"issuer":{"id":3496,"kind":"organization","name":"GLOBUS MEDICAL INC","symbol":"GMED"},"owners":[{"id":68880,"kind":"person","name":"Paul David C","position":1,"cik":"0001555391","reported_name":"Paul David C","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Executive Chairman"}}],"security":"Class A Common Stock","published_at":"2018-05-01T00:59:27.000Z","date":"2018-04-26","kind":"exercise","acquired":true,"shares":18461,"price":10.66,"value":196794.26,"ownership":{"direct":true},"balance_after":1096461,"source":{"system":"sec-edgar","filing":"0001209191-18-026950","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1237831/000120919118026950/doc4.xml","form_type":"4"}},{"id":3953511,"issuer":{"id":3496,"kind":"organization","name":"GLOBUS MEDICAL INC","symbol":"GMED"},"owners":[{"id":68880,"kind":"person","name":"Paul David C","position":1,"cik":"0001555391","reported_name":"Paul David C","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Executive Chairman"}}],"security":"Class A Common Stock","published_at":"2018-05-01T00:59:27.000Z","date":"2018-04-26","kind":"sale","acquired":false,"shares":18461,"price":51.8068,"value":956405.3348,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This sale was effected pursuant to a Rule 10b5-1 trading plan executed by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $51.80 to $52.155, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4."}],"balance_after":1078000,"source":{"system":"sec-edgar","filing":"0001209191-18-026950","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1237831/000120919118026950/doc4.xml","form_type":"4"}},{"id":3953510,"issuer":{"id":3496,"kind":"organization","name":"GLOBUS MEDICAL INC","symbol":"GMED"},"owners":[{"id":68880,"kind":"person","name":"Paul David C","position":1,"cik":"0001555391","reported_name":"Paul David C","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Executive Chairman"}}],"security":"Class A Common Stock","published_at":"2018-05-01T00:59:27.000Z","date":"2018-04-26","kind":"exercise","acquired":true,"shares":18461,"price":11.8625,"value":218993.6125,"ownership":{"direct":true},"balance_after":1096461,"source":{"system":"sec-edgar","filing":"0001209191-18-026950","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1237831/000120919118026950/doc4.xml","form_type":"4"}},{"id":3953509,"issuer":{"id":3496,"kind":"organization","name":"GLOBUS MEDICAL INC","symbol":"GMED"},"owners":[{"id":68880,"kind":"person","name":"Paul David C","position":1,"cik":"0001555391","reported_name":"Paul David C","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Executive Chairman"}}],"security":"Class A Common Stock","published_at":"2018-05-01T00:59:27.000Z","date":"2018-04-26","kind":"sale","acquired":false,"shares":18461,"price":51.8068,"value":956405.3348,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This sale was effected pursuant to a Rule 10b5-1 trading plan executed by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $51.80 to $52.155, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4."}],"balance_after":1078000,"source":{"system":"sec-edgar","filing":"0001209191-18-026950","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1237831/000120919118026950/doc4.xml","form_type":"4"}},{"id":3953508,"issuer":{"id":3496,"kind":"organization","name":"GLOBUS MEDICAL INC","symbol":"GMED"},"owners":[{"id":68880,"kind":"person","name":"Paul David C","position":1,"cik":"0001555391","reported_name":"Paul David C","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Executive Chairman"}}],"security":"Class A Common Stock","published_at":"2018-05-01T00:59:27.000Z","date":"2018-04-26","kind":"exercise","acquired":true,"shares":18461,"price":4.88,"value":90089.68,"ownership":{"direct":true},"balance_after":1096461,"source":{"system":"sec-edgar","filing":"0001209191-18-026950","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1237831/000120919118026950/doc4.xml","form_type":"4"}},{"id":4090944,"issuer":{"id":3496,"kind":"organization","name":"GLOBUS MEDICAL INC","symbol":"GMED"},"owners":[{"id":68880,"kind":"person","name":"Paul David C","position":1,"cik":"0001555391","reported_name":"Paul David C","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Executive Chairman"}}],"security":"Stock Option (Right to Buy Class A Common Stock)","published_at":"2018-01-24T21:11:51.000Z","date":"2018-01-22","kind":"grant","acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"These options were granted on January 22, 2018, and vest over a four-year period with one-fourth (1/4) of the options granted vesting on January 1, 2019, the first anniversary of the vesting commencement date, and the balance of the options granted vesting ratably on a monthly basis over the following 36 months."}],"balance_after":100000,"derivative":{"exercise_price":43.77,"expiration_date":"2028-01-22","underlying":"Class A Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001209191-18-005088","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1237831/000120919118005088/doc4.xml","form_type":"4"}},{"id":4473315,"issuer":{"id":3496,"kind":"organization","name":"GLOBUS MEDICAL INC","symbol":"GMED"},"owners":[{"id":68880,"kind":"person","name":"Paul David C","position":1,"cik":"0001555391","reported_name":"Paul David C","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (Right to Buy Class A Common Stock)","published_at":"2017-02-01T21:02:36.000Z","date":"2017-01-30","kind":"grant","acquired":true,"shares":150000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"These options were granted on January 30, 2017, and vest over a four-year period with one-fourth (1/4) of the options granted vesting on January 1, 2018, the first anniversary of the vesting commencement date, and the balance of the options granted vesting ratably on a monthly basis over the following 36 months"}],"balance_after":150000,"derivative":{"exercise_price":26.27,"expiration_date":"2027-01-30","underlying":"Class A Common Stock","underlying_shares":150000},"source":{"system":"sec-edgar","filing":"0001209191-17-006645","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1237831/000120919117006645/doc4.xml","form_type":"4"}}]}